Travoprost
Overview
Travoprost is a prostaglandin analog used for reducing intraocular pressure in patients with open-angle glaucoma or ocular hypertension. It works by increasing the outflow of aqueous humor from the eyes.
API suppliers (13)
Suppliers of Travoprost evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 11 of 13 suppliers.
5 of 13 hold a GMP certificate on record in the EU or UK registers
- DR REDDYS LABORATORIES LTD1 active DMF GMP on record
- CHIROGATE INTERNATIONAL INCTaiwan1 active DMF
- SCINOPHARM TAIWAN LTDTaiwan1 active DMF
- YS LIFE SCIENCE CO LTD1 active DMF
- Zhejiang Ausun Pharmaceutical Co., Ltd.China1 active DMF GMP on record
- CAYMAN PHARMA SROCzechia1 active DMF GMP on record
- DELTA BIOTECH SAArgentina1 active DMF
- Lupin LimitedIndia1 active DMF GMP on record
- MSN Laboratories Private LimitedIndia1 active DMF GMP on record
- EUROAPI HUNGARY LTDHungary1 active DMF
- GENTEC SABelgium1 active DMF
- EVERLIGHT CHEMICAL INDUSTRIAL CORPTaiwan
- Biocon LimitedIndia
Patent & exclusivity (US)
Per the FDA Orange Book (9 approved US products), the latest listed US patent on Travoprost expires 14 Feb 2031 and exclusivity 13 Dec 2026. Generic API sourcing typically opens up once these lapse.
Therapeutic areas
Do you supply Travoprost? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.